| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |